NINDS SBIR (U44) funding for exploratory neuroscience clinical trials via NeuroNEXT
NINDS invites SBIR Phase II (U44) applications from small businesses to conduct exploratory clinical trials or biomarker studies for non-stroke neurological disorders using the NeuroNEXT network. Applicants must use NeuroNEXT’s standardized infrastructure (CCC/DCC, master agreements, central IRB), and projects with independent third‑party investment receive priority. Phase 1b/2a multi-center a…
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers